The immune landscape in colorectal cancer: identifying exhaustion markers on tumor infiltrating CD8 using multiplex immunohistochemistry
Date
2023-07-31
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Saudi Digital Library
Abstract
Patients with colorectal cancer (CRC) have a significant proportion of exhausted tumor infiltrating CD8,
and that would reduce the efficacy of the immune response. Exhausted T cells characterized by impaired
cytokines secretion, decreased cytotoxicity and upregulation of inhibitory receptors such as T cell
immunoglobulin and mucin-3 (TIM-3), cytotoxic lymphocyte-activation gene - (LAG-3) and programmed
cell death-1 (PD-1). Accordingly, this study aimed to identify the expression of different exhaustion
markers on tumor infiltrating CD8 in CRC tissue samples. Chromogenic immunohistochemistry (IHC)
staining was used to optimize the concentrations of anti-LAG-3 and anti-TIM-3 using a whole CRC tissue
and tissue microarrays (TMAs). Consequently, optimized concentrations were used in multiplex
immunohistochemistry (IHC) staining to identify the expression of different exhaustion markers on the
surface of tumor infiltrating CD8. We found that concentrations of 1:100 of anti-LAG-3 and 1:400 of anti-
TIM-3 were the ideal ratios to provide positive expression with limited background staining in
chromogenic IHC. Additionally, our study revealed that multiplex IHC staining had successfully
demonstrated the presence of double positive cells including CD8+LAG-3+, CD8+TIM-3+, and CD8+PD-
1+. The presence of triple positive cells was detected in multiplex IHC including CD8+TIM-3+PD-1+ and
CD8+TIM-3+LAG-3+. In conclusion, after a successful optimization, this study was effectively recognized
the expression of different exhaustion markers on tumor infiltrating CD8, and the expression of triple
positive cells considered to be more exhausted than double positive cells. Hence, we suggest further
research should be conducted to investigate more exhaustion markers.
Description
Keywords
Tumor infiltrating CD8, Colorectal cancer, Exhausted T cell, Multiplex IHC